Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 9

1.

Reprogramming human A375 amelanotic melanoma cells by catalase overexpression: Upregulation of antioxidant genes correlates with regression of melanoma malignancy and with malignant progression when downregulated.

Bracalente C, Ibañez IL, Berenstein A, Notcovich C, Cerda MB, Klamt F, Chernomoretz A, Durán H.

Oncotarget. 2016 Jul 5;7(27):41154-41171. doi: 10.18632/oncotarget.9273.

2.

Reprogramming human A375 amelanotic melanoma cells by catalase overexpression: Reversion or promotion of malignancy by inducing melanogenesis or metastasis.

Bracalente C, Salguero N, Notcovich C, Müller CB, da Motta LL, Klamt F, Ibañez IL, Durán H.

Oncotarget. 2016 Jul 5;7(27):41142-41153. doi: 10.18632/oncotarget.9220.

3.

The redox-active nanomaterial toolbox for cancer therapy.

Ibañez IL, Notcovich C, Catalano PN, Bellino MG, Durán H.

Cancer Lett. 2015 Apr 1;359(1):9-19. doi: 10.1016/j.canlet.2015.01.013. Epub 2015 Jan 15. Review.

PMID:
25597786
4.

Cross-desensitization and cointernalization of H1 and H2 histamine receptors reveal new insights into histamine signal integration.

Alonso N, Fernandez N, Notcovich C, Monczor F, Simaan M, Baldi A, Gutkind JS, Davio C, Shayo C.

Mol Pharmacol. 2013 May;83(5):1087-98. doi: 10.1124/mol.112.083394. Epub 2013 Mar 5.

5.

Phosphorylation and subcellular localization of p27Kip1 regulated by hydrogen peroxide modulation in cancer cells.

Ibañez IL, Bracalente C, Notcovich C, Tropper I, Molinari BL, Policastro LL, Durán H.

PLoS One. 2012;7(9):e44502. doi: 10.1371/journal.pone.0044502. Epub 2012 Sep 6.

6.

The tumor microenvironment: characterization, redox considerations, and novel approaches for reactive oxygen species-targeted gene therapy.

Policastro LL, Ibañez IL, Notcovich C, Duran HA, Podhajcer OL.

Antioxid Redox Signal. 2013 Sep 10;19(8):854-95. doi: 10.1089/ars.2011.4367. Epub 2012 Oct 2. Review.

PMID:
22794113
7.

Histamine acting on H1 receptor promotes inhibition of proliferation via PLC, RAC, and JNK-dependent pathways.

Notcovich C, Diez F, Tubio MR, Baldi A, Kazanietz MG, Davio C, Shayo C.

Exp Cell Res. 2010 Feb 1;316(3):401-11. doi: 10.1016/j.yexcr.2009.11.002. Epub 2009 Nov 11.

PMID:
19913013
8.

Transcriptomic changes in human breast cancer progression as determined by serial analysis of gene expression.

Abba MC, Drake JA, Hawkins KA, Hu Y, Sun H, Notcovich C, Gaddis S, Sahin A, Baggerly K, Aldaz CM.

Breast Cancer Res. 2004;6(5):R499-513. Epub 2004 Jul 6. Erratum in: Breast Cancer Res. 2005;7(1):32.

9.

Reduction of G protein-coupled receptor kinase 2 expression in U-937 cells attenuates H2 histamine receptor desensitization and induces cell maturation.

Fernández N, Monczor F, Lemos B, Notcovich C, Baldi A, Davio C, Shayo C.

Mol Pharmacol. 2002 Dec;62(6):1506-14.

PMID:
12435819

Supplemental Content

Loading ...
Support Center